Skip to main content
. 2022 Feb 7;29(5):1344–1353. doi: 10.1111/ene.15251

FIGURE 1.

FIGURE 1

Flowchart shows participant selection. AC, anticholinergic medication; ADNI3, Alzheimer’s Disease Neuroimaging Initiative Phase 3; ChEI, cholinesterase inhibitor; CN, cognitively normal; fMRI, task‐free functional MRI; MCI, mild cognitive impairment [Colour figure can be viewed at wileyonlinelibrary.com]